SynAct Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-06 | SynAct Pharma AB | Uli Hacksell | Chairman of the Board of Directors | Acquisition | 6 000 | 14,2 | SEK | 85 200 | 2023-09-04 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 10 079 | 18,86 | SEK | 190 089,94 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 30 847 | 18,96 | SEK | 584 859,12 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 5 206 | 18,98 | SEK | 98 809,88 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 3 118 | 19 | SEK | 59 242 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 200 | 19,02 | SEK | 3 804 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 273 | 19,04 | SEK | 5 197,92 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 45 801 | 19,06 | SEK | 872 967,06 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 2 838 | 19,1 | SEK | 54 205,8 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 290 | 19,16 | SEK | 5 556,4 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 31 518 | 19,26 | SEK | 607 036,68 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 8 482 | 19,36 | SEK | 164 211,52 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 1 729 | 18,92 | SEK | 32 712,68 | 2023-09-06 |
| 2023-09-12 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 5 116 | 18,9 | SEK | 96 692,4 | 2023-09-06 |
| 2023-11-14 | SynAct Pharma AB | Thomas Jonass | Member of the Board of Directors | Demerger increase | 2 161 225 | 6,25 | SEK | 13 507 656,25 | 2023-11-08 |
| 2023-11-14 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors | Demerger decrease | 3 531 644 | 6,25 | SEK | 22 072 775 | 2023-11-08 |
| 2024-03-06 | SynAct Pharma AB | Thomas von Koch | Member of the Board of Directors | Acquisition | 1 118 210 | 6,8 | SEK | 7 603 828 | 2024-03-04 |
| 2024-03-06 | SynAct Pharma AB | Thomas von Koch | Member of the Board of Directors | Disposal | 1 118 210 | 6,8 | SEK | 7 603 828 | 2024-03-04 |
| 2024-03-25 | SynAct Pharma AB | Thomas Jonassen | Other member of the company's administrative, management or supervisory body | Dividend received | 245 870 | 6,9 | SEK | 1 696 503 | 2024-03-20 |
| 2024-03-25 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 14 250 | 6,9 | SEK | 98 325 | 2024-03-20 |